The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit
about
Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic reviewβ2-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through β-arrestin-dependent signaling.β-blockers in critically ill patients: from physiology to clinical evidence.Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
P2860
The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The safety of beta-blocker use ...... ure in the intensive care unit
@en
The safety of beta-blocker use ...... re in the intensive care unit.
@nl
type
label
The safety of beta-blocker use ...... ure in the intensive care unit
@en
The safety of beta-blocker use ...... re in the intensive care unit.
@nl
prefLabel
The safety of beta-blocker use ...... ure in the intensive care unit
@en
The safety of beta-blocker use ...... re in the intensive care unit.
@nl
P2093
P2860
P356
P1476
The safety of beta-blocker use ...... ure in the intensive care unit
@en
P2093
Can Yucel Karabay
Cuneyt Salturk
Feyza Kargin
Huriye Berk Takir
Merih Kalamanoglu Balci
Murat Yalcinsoy
Nalan Adiguzel
Nezihe Ciftaslan Goksenoglu
Ozlem Yazicioglu Mocin
Ramazan Kargin
P2860
P2888
P356
10.1186/2049-6958-9-8
P50
P577
2014-02-04T00:00:00Z
P5875
P6179
1021282636